相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Druggable Allosteric Sites in β-Propeller Lectins
Elena Shanina et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)
Selective Binding of Small Molecules to Vibrio cholerae DsbA Offers a Starting Point for the Design of Novel Antibacterials
Geqing Wang et al.
CHEMMEDCHEM (2022)
Development of Inhibitors of SAICAR Synthetase (PurC) from Mycobacterium abscessus Using a Fragment-Based Approach
Sitthivut Charoensutthivarakul et al.
ACS INFECTIOUS DISEASES (2022)
Fragment-based screening: A new paradigm for ligand and target discovery
Sinead Knight et al.
SLAS DISCOVERY (2022)
Covalent inhibitors of bacterial peptidoglycan biosynthesis enzyme MurA with chloroacetamide warhead
Katarina Grabrijan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Using Structure-guided Fragment-Based Drug Discovery to Target Pseudomonas aeruginosa Infections in Cystic Fibrosis
Sheikh Mohammed Arif et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2022)
A fragment-based drug discovery strategy applied to the identification of NDM-1 β-lactamase inhibitors
Jeremy Caburet et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Fragment-Based Drug Discovery against Mycobacteria: The Success and Challenges
Namdev S. Togre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Fragment-Based Phenotypic Lead Discovery To Identify New Drug Seeds That Target Infectious Diseases
Yann Ayotte et al.
ACS CHEMICAL BIOLOGY (2021)
Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds
Luke F. Duncan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Fragment-based screening and hit-based substructure search: Rapid discovery of 8-hydroxyquinoline-7-carboxylic acid as a low-cytotoxic, nanomolar metallo β-lactamase inhibitor
Woo Shik Shin et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2021)
QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics
Olga Lomovskaya et al.
FRONTIERS IN MICROBIOLOGY (2021)
Fragment-based drug discovery: opportunities for organic synthesis
Jeffrey D. St Denis et al.
RSC MEDICINAL CHEMISTRY (2021)
Fragment-based covalent ligand discovery
Wenchao Lu et al.
RSC CHEMICAL BIOLOGY (2021)
Flexible Fragment Growing Boosts Potency of Quorum-Sensing Inhibitors against Pseudomonas aeruginosa Virulence
Michael Zender et al.
CHEMMEDCHEM (2020)
Discovery of novel tRNA-amino acid dual-site inhibitors against threonyl-tRNA synthetase by fragment-based target hopping
Junsong Guo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Bin Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Biochemical Characterization of QPX7728, a New Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases
Ruslan Tsivkovski et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
A novel potent metal-binding NDM-1 inhibitor was identified by fragment virtual, SPR and NMR screening
Huifang Guo et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Iminodiacetic Acid as a Novel Metal-Binding Pharmacophore for New Delhi Metallo-β-lactamase Inhibitor Development
Allie Y. Chen et al.
CHEMMEDCHEM (2020)
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
ANT2681: SAR Studies Leading to the Identification of a Metallo-ß-lactamase Inhibitor with Potential for Clinical Use in Combination with Meropenem for the Treatment of Infections Caused by NDM-Producing Enterobacteriaceae
David T. Davies et al.
ACS INFECTIOUS DISEASES (2020)
Functional Genomics for Target Identification
Davide Gianni et al.
SLAS DISCOVERY (2020)
Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification
Sherine E. Thomas et al.
NUCLEIC ACIDS RESEARCH (2020)
Fragment-based target screening as an empirical approach to prioritising targets: a case study on antibacterials
Peter Canning et al.
DRUG DISCOVERY TODAY (2020)
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity
Yousuke Yamada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
From Phenotypic Hit to Chemical Probe: Chemical Biology Approaches to Elucidate Small Molecule Action in Complex Biological Systems
Quentin T. L. Pasquer et al.
MOLECULES (2020)
Targeting Metalloenzymes for Therapeutic Intervention
Allie Y. Chen et al.
CHEMICAL REVIEWS (2019)
Cell Wall Hydrolases in Bacteria: Insight on the Diversity of Cell Wall Amidases, Glycosidases and Peptidases Toward Peptidoglycan
Aurore Vermassen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Targeting the Bacterial Epitranscriptome for Antibiotic Development: Discovery of Novel tRNA-(N1G37) Methyltransferase (TrmD) Inhibitors
Wenhe Zhong et al.
ACS INFECTIOUS DISEASES (2019)
Development of Inhibitors against Mycobacterium abscessus tRNA (m1G37) Methyltransferase (TrmD) Using Fragment-Based Approaches
Andrew J. Whitehouse et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Optimization of LpxC Inhibitors for Antibacterial Activity and Cardiovascular Safety
Frederick Cohen et al.
CHEMMEDCHEM (2019)
Thienopyrimidinone Derivatives That Inhibit Bacterial tRNA (Guanine37-N1)-Methyltransferase (TrmD) by Restructuring the Active Site with a Tyrosine-Flipping Mechanism
Wenhe Zhong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Targeted 8-hydroxyquinoline fragment based small molecule drug discovery against neglected botulinum neurotoxin type F
Ritika Chauhan et al.
BIOORGANIC CHEMISTRY (2019)
The Fragment-Based Development of a Benzofuran Hit as a New Class of Escherichia coli DsbA Inhibitors
Luke F. Duncan et al.
MOLECULES (2019)
Concepts and Core Principles of Fragment-Based Drug Design
Philine Kirsch et al.
MOLECULES (2019)
Expedited mapping of the ligandable proteome using fully functionalized enantiomeric probe pairs
Yujia Wang et al.
NATURE CHEMISTRY (2019)
Lectin antagonists in infection, immunity, and inflammation
Joscha Meiers et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2019)
Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design
Pasquale Linciano et al.
ACS INFECTIOUS DISEASES (2019)
Probing the Interaction of Aspergillomarasmine A with Metallo-beta-lactamases NDM-1, VIM-2, and IMP-7
Alexander Bergstrom et al.
ACS INFECTIOUS DISEASES (2018)
Fragment-Based Phenotypic Lead Discovery: Cell-Based Assay to Target Leishmaniasis
Yann Ayotte et al.
CHEMMEDCHEM (2018)
Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria
Robert J. Moreau et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Fragment-Based Approach to Targeting Inosine-5′-monophosphate Dehydrogenase (IMPDH) from &ITMycobacterium tuberculosis&IT
Ana Trapero et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity
Colin K. Skepper et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Ricky Cain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Drugging tRNA aminoacylation
Joanne M. Ho et al.
RNA BIOLOGY (2018)
Using Fragment-Based Approaches to Discover New Antibiotics
Bas Lamoree et al.
SLAS DISCOVERY (2018)
Application of fragment based virtual screening towards inhibition of bacterial N-acetyglucosaminidase$
T. Tibaut et al.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH (2018)
Heterocyclic electrophiles as new MurA inhibitors
Aaron Keeley et al.
ARCHIV DER PHARMAZIE (2018)
Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular
Dereje A. Negatu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Fragment-Based Discovery of Inhibitors of the Bacterial DnaG-SSB Interaction
Zorik Chilingaryan et al.
ANTIBIOTICS-BASEL (2018)
Current perspectives in fragment-based lead discovery (FBLD)
Bas Lamoree et al.
STRUCTURE-BASED DRUG DESIGN: INSIGHTS FROM ACADEMIA AND INDUSTRY (2017)
LpxC inhibitors: a patent review (2010-2016)
Dmitrii V. Kalinin et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2017)
Predictive compound accumulation rules yield a broad - spectrum antibiotic
Michelle F. Richter et al.
NATURE (2017)
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis
Vitul Jain et al.
STRUCTURE (2017)
2-Chloropropionamide As a Low-Reactivity Electrophile for Irreversible Small-Molecule Probe Identification
Dharmaraja Allimuthu et al.
ACS CHEMICAL BIOLOGY (2017)
Mechanism of inhibition of botulinum neurotoxin type A light chain by two quinolinol compounds
Yacoba V. T. Minnow et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2017)
Targeting tuberculosis using structure-guided fragment-based drug design
Vitor Mendes et al.
DRUG DISCOVERY TODAY (2017)
Trm5 and TrmD: Two Enzymes from Distinct Origins Catalyze the Identical tRNA Modification, m1G37
Sakurako Goto-Ito et al.
BIOMOLECULES (2017)
Ligand and Target Discovery by Fragment-Based Screening in Human Cells
Christopher G. Parker et al.
CELL (2017)
Why Hydroxamates May Not Be the Best Histone Deacetylase InhibitorsWhat Some May Have Forgotten or Would Rather Forget?
Sida Shen et al.
CHEMMEDCHEM (2016)
Substrate independent ATPase activity may complicate high throughput screening
Micheal L. Tuntland et al.
ANALYTICAL BIOCHEMISTRY (2016)
Small molecule non-peptide inhibitors of botulinum neurotoxin serotype E: Structure-activity relationship and a pharmacophore model
Gyanendra Kumar et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Identification of small molecule inhibitors of botulinum neurotoxin serotype E via footprint similarity
Yuchen Zhou et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
Juergen Brem et al.
NATURE COMMUNICATIONS (2016)
Antibacterial Drug Discovery Targeting the Lipopolysaccharide Biosynthetic Enzyme LpxC
Alice L. Erwin
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Fragment-Based Whole Cell Screen Delivers Hits against M-tuberculosis and Non-tuberculous Mycobacteria
Wilfried Moreira et al.
FRONTIERS IN MICROBIOLOGY (2016)
Inosine 5′-monophosphate dehydrogenase inhibitors as antimicrobial agents: recent progress and future perspectives
Chetan P. Shah et al.
FUTURE MEDICINAL CHEMISTRY (2015)
Catalytic pathway, substrate binding and stability in SAICAR synthetase: A structure and molecular dynamics study
Kavyashree Manjunath et al.
JOURNAL OF STRUCTURAL BIOLOGY (2015)
Mycobacterium tuberculosis IMPDH in Complexes with Substrates, Products and Antitubercular Compounds
Magdalena Makowska-Grzyska et al.
PLOS ONE (2015)
Essential genome of Pseudomonas aeruginosa in cystic fibrosis sputum
Keith H. Turner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Structural basis for full-spectrum inhibition of translational functions on a tRNA synthetase
Pengfei Fang et al.
NATURE COMMUNICATIONS (2015)
Application of Fragment-Based Screening to the Design of Inhibitors of Escherichia coli DsbA
Luke A. Adams et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain
Dejan Caglic et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Optimization of Pyrrolamide Topoisomerase II Inhibitors Toward Identification of an Antibacterial Clinical Candidate (AZD5099)
Gregory S. Basarab et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Chasing acyl carrier protein through a catalytic cycle of lipid A production
Ali Masoudi et al.
NATURE (2014)
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
Andrew M. King et al.
NATURE (2014)
Is there new hope for therapeutic matrix metalloproteinase inhibition?
Roosmarijn E. Vandenbroucke et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Diversity in ATP concentrations in a single bacterial cell population revealed by quantitative single-cell imaging
Hideyuki Yaginuma et al.
SCIENTIFIC REPORTS (2014)
Structures of SAICAR synthetase (PurC) from Streptococcus pneumoniae with ADP, Mg2+, AIR and Asp
Nina M. Wolf et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2014)
Discovery of Inhibitors of 4′-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for Antibacterial Therapy
Boudewijn L. M. de Jonge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Design and Evaluation of the Performance of an NMR Screening Fragment Library
Bradley C. Doak et al.
AUSTRALIAN JOURNAL OF CHEMISTRY (2013)
Identification of Bacteria-Selective Threonyl-tRNA Synthetase Substrate Inhibitors by Structure-Based Design
Min Teng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Selective Inhibitors of Bacterial t-RNA-(N1G37) Methyltransferase (TrmD) That Demonstrate Novel Ordering of the Lid Domain
Pamela J. Hill et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Optimization of Benzoxazole-Based Inhibitors of Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase
Suresh Kumar Gorla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase
Huihao Zhou et al.
NATURE (2013)
blaNDM-1 Is a Chimera Likely Constructed in Acinetobacter baumannii
M. A. Toleman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Discovery of Antagonists of PqsR, a Key Player in 2-Alkyl-4-quinolone-Dependent Quorum Sensing in Pseudomonas aeruginosa
Cenbin Lu et al.
CHEMISTRY & BIOLOGY (2012)
Architecture and Conservation of the Bacterial DNA Replication Machinery, an Underexploited Drug Target
Andrew Robinson et al.
CURRENT DRUG TARGETS (2012)
Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present
Bharat Gadakh et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2012)
Fucose-binding Lectin from Opportunistic Pathogen Burkholderia ambifaria Binds to Both Plant and Human Oligosaccharidic Epitopes
Aymeric Audfray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase
Tracy L. Keller et al.
NATURE CHEMICAL BIOLOGY (2012)
Purine Salvage Pathway in Mycobacterium tuberculosis
R. G. Ducati et al.
CURRENT MEDICINAL CHEMISTRY (2011)
The Antibiotic Potential of Prokaryotic IMP Dehydrogenase Inhibitors
L. Hedstrom et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Crystal structure of NDM-1 reveals a common β-lactam hydrolysis mechanism
HongMin Zhang et al.
FASEB JOURNAL (2011)
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
Karthikeyan K. Kumarasamy et al.
LANCET INFECTIOUS DISEASES (2010)
Identification and Biochemical Characterization of Small-Molecule Inhibitors of Clostridium botulinum Neurotoxin Serotype A
Virginia Roxas-Duncan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin A: Effects of zinc ion and peptides on inhibition
Huiguo Lai et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2009)
IMP Dehydrogenase: Structure, Mechanism, and Inhibition
Lizbeth Hedstrom
CHEMICAL REVIEWS (2009)
The nature of Staphylococcus aureus MurA and MurZ and approaches for detection of peptidoglycan biosynthesis inhibitors
Katy L. Blake et al.
MOLECULAR MICROBIOLOGY (2009)
From carbohydrate leads to glycomimetic drugs
Beat Ernst et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
SSB as an Organizer/Mobilizer of Genome Maintenance Complexes
Robert D. Shereda et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Membrane lipid homeostasis in bacteria
Yong-Mei Zhang et al.
NATURE REVIEWS MICROBIOLOGY (2008)
Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery
Qingning Shu et al.
MEDICINAL RESEARCH REVIEWS (2008)
An antifungal agent inhibits an aminoacyl-tRNA synthetase by trapping tRNA in the editing site
Fernando L. Rock et al.
SCIENCE (2007)
Evolution of carbohydrate antigens - microbial forces shaping host glycomes?
Joseph R. Bishop et al.
GLYCOBIOLOGY (2007)
Octameric structure of the human bifunctional enzyme PAICS in purine biosynthesis
Shu-Xing Li et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
An integrated approach to fragment-based lead generation: Philosophy, strategy and case studies from AstraZeneca's drug discovery programmes
Jeffrey S. Albert et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
Nucleotide complexes of Escherichia coli phosphoribosylaminoimidazole succinocarboxamide synthetase
Nathaniel D. Ginder et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mechanisms of antimicrobial resistance in bacteria
Fred C. Tenover
AMERICAN JOURNAL OF MEDICINE (2006)
ZINC - A free database of commercially available compounds for virtual screening
JJ Irwin et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2005)
Coenzyme A biosynthesis: Reconstruction of the pathway in archaea and an evolutionary scenario based on comparative genomics
U Genschel
MOLECULAR BIOLOGY AND EVOLUTION (2004)
Induced fit and kinetic mechanism of adenylation catalyzed by Escherichia coli threonyl-tRNA synthetase
ML Bovee et al.
BIOCHEMISTRY (2003)
Inhibitors of phosphopantetheine adenylyltransferase
LH Zhao et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2003)
Genes required for mycobacterial growth defined by high density mutagenesis
CM Sassetti et al.
MOLECULAR MICROBIOLOGY (2003)
Why are bacteria refractory to antimicrobials?
D Hogan et al.
CURRENT OPINION IN MICROBIOLOGY (2002)
Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics
M Daugherty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A genome-wide strategy for the identification of essential genes in Staphylococcus aureus
RA Forsyth et al.
MOLECULAR MICROBIOLOGY (2002)
Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture
F Zouhiri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Aminoacyl-tRNA synthetases, the genetic code, and the evolutionary process
CR Woese et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2000)